10-Q · August 14, 2026
Greenland Mines completed its transformation into a combined Biotech and Mining company, but remained pre-revenue with $0 revenue and a net loss of $13,857,203 versus $2,116,726 in the prior-year quarter. Operating…
Earnings analysis · 10-Q
GRML earnings analysis
Filed August 17, 2026 · Our reading of the company's report
The latest report
The provided excerpt does not include the income statement, balance sheet, cash-flow statement, segment data, or quantitative outlook, so current-period revenue, margins, EPS, and free cash flow cannot be assessed. The…
Read full summary
The provided excerpt does not include the income statement, balance sheet, cash-flow statement, segment data, or quantitative outlook, so current-period revenue, margins, EPS, and free cash flow cannot be assessed. The principal update is that disclosure controls remained ineffective as of June 30, 2026, with three identified control areas not fully remediated. Ongoing remediation and reliance on management oversight and external professionals are constructive, but the unresolved weaknesses create elevated reporting and execution risk.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
What stood out
-
Financial statements deemed fairly stated
As of June 30, 2026, management stated that the condensed consolidated financial statements for the three and six months ended June 30, 2026 were fairly stated in all material respects under U.S. GAAP, despite control deficiencies.
-
Internal-control remediation underway
Management initiated remediation activities as of June 30, 2026, including a risk assessment, enhanced and newly implemented controls, key-control testing, and documentation of enhanced processes.
-
No insider trading arrangements
The filing states that no directors or officers adopted or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the quarter ended June 30, 2026.
What to watch
-
Disclosure controls remain ineffective
As of June 30, 2026, management concluded that disclosure controls and procedures were not effective to provide reasonable assurance that required information would be recorded, processed, summarized, reported, and communicated on a timely basis.
-
Three control weaknesses unresolved
As of June 30, 2026, material weaknesses remained in inadequate accounting resources, segregation of duties, and the broader internal-control environment; remediation had not been fully completed.
-
Limited accounting resources constrain remediation
The filing states that the small size of the outsourced accounting staff may prevent adequate control remediation in the future because of the cost-benefit tradeoff, creating a continuing risk of financial-statement misstatement.
Management's outlook
The provided filing excerpt contains no quantitative revenue or EPS outlook. Management discusses ongoing remediation of internal-control weaknesses but does not provide operating guidance.
Earlier filings 4
10-K · August 14, 2026
Greenland Mines is undergoing a major strategic transformation from a pre-revenue medical research company into a combined biotechnology and mining enterprise, but the acquired mining assets have not yet produced…
10-Q · May 20, 2026
Greenland Mines Ltd (NASDAQ: GRML) reported Q4 2026 results with no revenue and a net loss of $14.1 million, a significant decline compared to a net loss of $2.1 million in Q4 2025. Operating expenses increased notably…
10-K · April 1, 2026
Greenland Mines Ltd (formerly Klotho Neurosciences) is an early-stage company focused on a proprietary s‑KL (α‑Klotho secreted isoform) gene‑therapy platform (KLTO‑101, KLTO‑202) plus an acquired portfolio of off‑patent…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.